Germany · Delayed Price · Currency is EUR Bicycle Therapeutics Statistics
Total Valuation
FRA:50BA has a market cap or net worth of EUR 261.63 million. The enterprise value is -163.57 million.
| Market Cap | 261.63M |
| Enterprise Value | -163.57M |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 39.59% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.88 |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.08, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.08 |
| Quick Ratio | 11.70 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -1,067.88 |
Financial Efficiency
Return on equity (ROE) is -32.30% and return on invested capital (ROIC) is -21.45%.
| Return on Equity (ROE) | -32.30% |
| Return on Assets (ROA) | -17.91% |
| Return on Invested Capital (ROIC) | -21.45% |
| Return on Capital Employed (ROCE) | -36.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 186,016 |
| Profits Per Employee | -578,707 |
| Employee Count | 288 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:50BA has paid 1.52 million in taxes.
| Income Tax | 1.52M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -38.80% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 4.36 |
| Relative Strength Index (RSI) | 58.52 |
| Average Volume (20 Days) | 50 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.68 |
Income Statement
In the last 12 months, FRA:50BA had revenue of EUR 53.57 million and -166.67 million in losses. Loss per share was -2.40.
| Revenue | 53.57M |
| Gross Profit | -111.91M |
| Operating Income | -180.40M |
| Pretax Income | -165.15M |
| Net Income | -166.67M |
| EBITDA | -175.77M |
| EBIT | -180.40M |
| Loss Per Share | -2.40 |
Balance Sheet
The company has 446.45 million in cash and 12.83 million in debt, with a net cash position of 433.62 million.
| Cash & Cash Equivalents | 446.45M |
| Total Debt | 12.83M |
| Net Cash | 433.62M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 446.63M |
| Book Value Per Share | 6.40 |
| Working Capital | 461.81M |
Cash Flow
In the last 12 months, operating cash flow was -180.36 million and capital expenditures -1.95 million, giving a free cash flow of -182.30 million.
| Operating Cash Flow | -180.36M |
| Capital Expenditures | -1.95M |
| Depreciation & Amortization | 4.54M |
| Net Borrowing | -168,160 |
| Free Cash Flow | -182.30M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -208.89% |
| Operating Margin | -336.74% |
| Pretax Margin | -308.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:50BA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.52% |
| Shareholder Yield | -0.52% |
| Earnings Yield | -63.70% |
| FCF Yield | -69.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:50BA has an Altman Z-Score of 0.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.43 |
| Piotroski F-Score | 3 |